acetaminophen 300 MG / oxycodone hydrochloride 2.5 MG Oral Tablet [Nalocet]

RxCUI
2045500
RxNorm name
acetaminophen 300 MG / oxycodone hydrochloride 2.5 MG Oral Tablet [Nalocet]
Display name
NALOCET (Oral Pill)
Full name
acetaminophen 300 MG / oxycodone hydrochloride 2.5 MG Oral Tablet [Nalocet]
Term type
SBD
Status
Active
Strength
300-2.5 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-11-06 11:40:51

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062018
Active start
062018
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
acetaminophen300 MG / 1 EACHacetaminophenacetaminophen
oxycodone hydrochloride2.5 MG / 1 EACHoxycodoneoxycodone hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
acetaminophen161
oxycodone7804

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
72245-193-0372245-193Nalocet oxycodone and acetaminophenForte Bio-Pharma LLCANDA040608
72245-193-1072245-193Nalocet oxycodone and acetaminophenForte Bio-Pharma LLCANDA040608

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA04060872245-193Nalocet oxycodone and acetaminophenANDAForte Bio-Pharma LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11SourceActive
72245019303rxnav_ndcsyes
72245019310rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NalocetOXYCODONE AND ACETAMINOPHENForte Bio-Pharma LLCf5f7dfca-a5c7-4445-8a5e-9ec62f33f5be2026-08-06Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 72245-193-03
ndc (package): 72245-193-10
ndc (product): 72245-193
ndc11 (package): 72245019310
ndc11 (package): 72245019303
rxcui: 2045500

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f5f7dfca-a5c7-4445-8a5e-9ec62f33f5beNalocet 2.5 MG / 300 MG Oral Tablet [PSN] · acetaminophen 300 MG / oxycodone hydrochloride 2.5 MG Oral Tablet [Nalocet] [SBD] · APAP 300 MG / Oxycodone Hydrochloride 2.5 MG Oral Tablet [Nalocet] [SY] · Nalocet (oxycodone HCl 2.5 MG / acetaminophen 300 MG) Oral Tablet [SY]48Nalocet20260423

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
f5f7dfca-a5c7-4445-8a5e-9ec62f33f5beNalocetForte Bio-Pharma LLC20260806
f5f7dfca-a5c7-4445-8a5e-9ec62f33f5beNalocetForte Bio-Pharma LLC20260603
f5f7dfca-a5c7-4445-8a5e-9ec62f33f5beNalocetForte Bio-Pharma LLC20260423
f5f7dfca-a5c7-4445-8a5e-9ec62f33f5beNalocetForte Bio-Pharma LLC20260316

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN02BEAnilidesATC1-4acetaminophen
ATCN02AANatural opium alkaloidsATC1-4oxycodone
FDASPLN0000175690Opioid AgonistEPChas_epcoxycodone
FDASPLN0000175684Full Opioid AgonistsMOAhas_moaoxycodone
MEDRTD000082AcetaminophenCHEMhas_ingredientacetaminophen
MEDRTD010098OxycodoneCHEMhas_ingredientoxycodone
MEDRTD010098OxycodoneCHEMhas_ingredientoxycodone hydrochloride
MEDRTD001249AsthmaDISEASEci_withoxycodone hydrochloride
MEDRTD001249AsthmaDISEASEci_withoxycodone
MEDRTD004342Drug HypersensitivityDISEASEci_withoxycodone hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withoxycodone
MEDRTD004342Drug HypersensitivityDISEASEci_withacetaminophen
MEDRTD005334FeverDISEASEmay_preventacetaminophen
MEDRTD005334FeverDISEASEmay_treatacetaminophen
MEDRTD005955Glucosephosphate Dehydrogenase DeficiencyDISEASEci_withacetaminophen
MEDRTD007415Intestinal ObstructionDISEASEci_withoxycodone hydrochloride
MEDRTD007415Intestinal ObstructionDISEASEci_withoxycodone
MEDRTD007418Intestinal Pseudo-ObstructionDISEASEci_withoxycodone
MEDRTD007418Intestinal Pseudo-ObstructionDISEASEci_withoxycodone hydrochloride
MEDRTD008107Liver DiseasesDISEASEci_withacetaminophen
MEDRTD010146PainDISEASEmay_treatacetaminophen
MEDRTD010146PainDISEASEmay_preventacetaminophen
MEDRTD010149Postoperative PainDISEASEmay_treatoxycodone hydrochloride
MEDRTD010149Postoperative PainDISEASEmay_treatoxycodone
MEDRTD011247PregnancyDISEASEci_withoxycodone
MEDRTD011247PregnancyDISEASEci_withoxycodone hydrochloride
MEDRTD012131Respiratory InsufficiencyDISEASEci_withoxycodone hydrochloride
MEDRTD012131Respiratory InsufficiencyDISEASEci_withoxycodone
MEDRTN0000175684Full Opioid AgonistsMOAhas_moaoxycodone hydrochloride
MEDRTN0000175684Full Opioid AgonistsMOAhas_moaoxycodone
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moaacetaminophen
MEDRTN0000175439AnalgesiaPEhas_peoxycodone hydrochloride
MEDRTN0000175439AnalgesiaPEhas_peoxycodone
MEDRTN0000175724Central Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000008635Decreased GI MotilityPEhas_peoxycodone
MEDRTN0000008635Decreased GI MotilityPEhas_peoxycodone hydrochloride
MEDRTN0000008701Decreased Medullary Respiratory DrivePEhas_peoxycodone
MEDRTN0000008701Decreased Medullary Respiratory DrivePEhas_peoxycodone hydrochloride
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_peoxycodone
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_peoxycodone hydrochloride
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peacetaminophen
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_peacetaminophen
MEDRTN0000009353Increased Histamine ProductionPEhas_peoxycodone hydrochloride
MEDRTN0000009353Increased Histamine ProductionPEhas_peoxycodone
MEDRTN0000175725Peripheral Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000000026Hepatic MetabolismPKhas_pkacetaminophen
MEDRTN0000000042Renal ExcretionPKhas_pkacetaminophen

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH300 MG / 2.5 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE2
CODESANDAANDA040608
NAMESPrescribable SynonymNalocet 2.5 MG / 300 MG Oral Tablet
NAMESTallman Synonymacetaminophen 300 MG / oxyCODONE hydrochloride 2.5 MG Oral Tablet [Nalocet]
NAMESTallman SynonymAPAP 300 MG / oxyCODONE Hydrochloride 2.5 MG Oral Tablet [Nalocet]
NAMESTallman SynonymNalocet (oxyCODONE HCl 2.5 MG / acetaminophen 300 MG) Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon